The Cancer Moonshot ECCO2018 September 7, 2018
|
|
- Louise Martin
- 5 years ago
- Views:
Transcription
1 The Cancer Moonshot ECCO2018 September 7, 2018 Dinah S. Singer, Ph.D. Deputy Director National Cancer Institute, NIH
2 Goals of the Cancer Moonshot Accelerate progress in cancer, including prevention & screening From cutting edge basic research to wider uptake of standard of care Encourage greater cooperation and collaboration Within and between academia, government, and private sector Enhance data sharing (Presidential Memo 2016) Blue Ribbon Panel 2016
3 Blue Ribbon Panel The Blue Ribbon Panel will provide expert advice on the vision, proposed scientific goals, and implementation of the National Cancer Moonshot...The panel may also recommend other cancer research activities to enhance this effort. The Panel will provide an intensive examination of the opportunities and impediments in cancer research Findings and recommendations of the Panel will be reported to the NCAB. The NCAB will use the Panel s findings and recommendations to provide final recommendations to the NCI Director. (Presidential Memo 2016) Blue Ribbon Panel 2016
4 Blue Ribbon Panel 28 Members Clinicians, researchers, advocates, representatives from pharma and IT Three face-to-face meetings to identify Moonshot recommendations 7 Working Groups Clinical trials, enhanced data sharing, cancer immunology, tumor evolution, implementation science, pediatric cancer, precision prevention and early detection Each group had members. In total, ~150 individuals were actively involved Met weekly for 6 weeks to generate 2-3 recommendations/working group of major scientific opportunities poised for acceleration Blue Ribbon Panel 2016
5 Scientific and Community Outreach Activities Goal: Provide opportunities for the public and experts ways to submit ideas Increase the public s participation in the Cancer Moonshot Approaches: Online public idea repository over 1600 ideas submitted One-on-one public input: BRP Listening sessions Professional conferences Response: Over 1600 ideas received Blue Ribbon Panel 2016
6 Overview of Blue Ribbon Panel Report The Report summarizes the recommendations of exceptional research opportunities that could lead to powerful advances in our understanding of cancer The online Report includes all recommendations in their entirety at Blue Ribbon Panel 2016
7 Blue Ribbon Panel Recommendations A. Network for direct patient engagement B. Cancer immunotherapy translational science network C. Therapeutic target identification to overcome drug resistance D. Creation of a national cancer data ecosystem E. Fusion oncoproteins in pediatric cancer F. Symptom management research G. Precision prevention and early detection H. Retrospective analysis of biospecimens from patients treated with standard of care I. Creation of human tumor atlas J. Development of new enabling technologies Cross Cutting Themes: Health disparities, prevention, data sharing, partnerships
8 Cancer Funding in 21 st Century Cures Act The cancer research portion is named the Beau Biden Cancer Moonshot Initiative $1.8 billion over 7 years $300 million for FY17 $300 million for FY18 To support cancer research, such as the development of cancer vaccines, the development of more sensitive diagnostic tests for cancer, immunotherapy and the development of combination therapies, research that has the potential to transform the scientific field that has inherently higher risk, and that seeks to address major challenges associated with cancer.
9 Cancer Moonshot Initiatives
10 Cancer Moonshot Potential International Collaborations Japan Korea Australia Ireland Serbia Sweden Germany Poland Taiwan Denmark United Kingdom Norway
11 Questions?
12 A Few of the 2018 Cancer Moonshot Initiatives Immuno-Oncology Translation Network Fusion Oncoproteins in Childhood Cancers Consortium Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes Human Tumor Atlas Network Accelerating CRC Screening & Follow-up through Implementation Science (ACCSIS) Rare Tumor Patient Engagement Network
13 Immuno-Oncology Translational Network (IOTN) Recommendation: Accelerate translation of basic discoveries to clinical applications to improve immunotherapy outcomes for both hot and cold cancers Implementation: Leverage the expertise and resources of a collaborative network of investigators focused on improving immunotherapy approaches The IOTN collaborates with other NCI Programs: o PREVENT, Early Clinical Trials, and ETCTN Cancer Immunotherapy Consortium Partnerships * Immunoprevention Pancreatic Data Management and Steering Resource Committee Center Steering Committee Lung Ovarian Immunogenomics Resource Centers o o o Cancer Immunotherapy Trials Network CIMACs and Data Commons Network Canine Immunotherapy Trials Prostate # TNBC ^MSI hi *GBM, Head & Neck, etc. Sync d with Tumor Atlas Group Colorectal^ Breast # Cell Therapy Data Registry & Biorepository o Pediatric Immunotherapy Discovery and Development Network
14 Drug targets? Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium Recommendation: Improve our understanding of fusion oncoproteins in pediatric cancer. Implementation: Creation of a multi-disciplinary consortium of research teams taking a comprehensive approach to understanding the biology of fusion oncoproteins and developing therapeutics. EWSR1 FLI1 TAD TAD X EWSR FLI DBD DBD Fusion Oncoproteins o 3 Centers: Research Projects, Administrative Core, and Shared Resource Cores Focus on high risk fusion-driven cancers without existing effective targeted agents. Altered transcription complexes Aberrant activation of developmentally regulated genes Tumor initiation and progression
15 Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes Recommendation: Improve prevention and early detection for individuals with an inherited predisposition and high risk for cancer. Implementation: Support collaborative, multidisciplinary research projects investigating the detection of hereditary cancers and delivery of care for high-risk individuals o o o Evidence-based services Behavioral and psychosocial effects of genetic testing Best practices for diagnostic and follow-up care Involves the development of sustainable approaches in diverse care settings and populations
16 Human Tumor Atlas Network Experimental Measurements (HTAN) Recommendation: Generate 3D and 4D atlases of tumors over time Human Tumor Atlases o Describe molecular, cellular, and physiological events across multiple scales o Enable predictive modeling o Span from premalignancy to metastasis Implementation: Create a collaborative network to build high-priority human tumor atlases to understand transitions in cancer o HTA and Pre-Cancer Research Centers o Coordinating Center o NCI CCR Project Figure from A. Regev and HTAPP Team
17 Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS) Recommendation: Generate effective implementation strategies that substantially improve early cancer detection ACCSIS Signature Trial Implementation: Signature Trial to determine effective implementation approaches to increase colorectal cancer (CRC) screening o 3 Research Projects and a Coordinating Center Emphasis on addressing disparities in CRC screening and follow-up, including: o o o Underserved racial and ethnic minority populations Rural and hard-to-reach populations High-risk subgroups Phase 1 (UG3) Phase 2 (UH3) Pilot Test Feasibility and pilot testing of multilevel intervention among a target population Comparative effectiveness trial of implementation strategies to increase CRC screening and follow-up
18 Rare Tumor Patient Engagement Network Funded by the Cancer Moonshot. Build a national network to study selected rare pediatric and adult tumors and develop a network of clinical trials. Partnering with patient advocacy networks. Partnering with centers of excellence to broaden the reach and impact. NCI-CONNECT Comprehensive Oncology Network Evaluating Rare CNS Tumors Leaders: Mark Gilbert, M.D., and Terri Arm strong, P h.d. Aims to advance our understanding of adult rare central nervous system cancers by establishing and fostering patient-advocacy-provider partnerships and networks to improve approaches to care and treatment. MyPART Moonshot Pediatric, Adolescent, and Adult Rare Tumors Netw ork Leaders: Karlyn e R e i l l y, Ph.D., and Brigitte W i d e mann, M.D. To increase patient and patient family involvement in rare tumor research and develop new therapies for rare pediatric and adult solid tumors through increased understanding of tumor biology and natural history
19 Summary of the Recommendations A. Network for direct patient engagement: Enlist patients in federated network where patients can pre-register for clinical trials and contribute their tumor profile data to expand knowledge about what therapies work and in whom. B. Cancer immunotherapy translation network. Organize a network to discover and evaluate novel immune-based approaches for adult and pediatric cancers, and eventually develop vaccines. C. Therapeutic target identification to overcome drug resistance. Launch interdisciplinary studies to delineate mechanisms that lead cancer cells to become resistant to previously effective treatments. D. Creation of a national cancer data ecosystem. Create an ecosystem to collect, share, and interconnect datasets. Blue Ribbon Panel 2016
20 Summary of the Recommendations (continued) E. Fusion oncoproteins in pediatric cancer. Improve understanding of the abnormal fusion proteins that result from chromosomal translocations and drive many pediatric cancers. F. Symptom management research. Support research to accelerate development of guidelines for management of patient-reported symptoms to improve quality of life and adherence to treatment regimens. G. Precision prevention and early detection: Implementation of evidence-based approaches. Conduct implementation science research to encourage broader adoption of HPV vaccination, colorectal cancer screening, and tobacco cessation. Blue Ribbon Panel 2016
21 Summary of the Recommendations (continued) H. Retrospective analysis of biospecimens from patients treated with standard of care. Analyze biopsies to learn which features predict outcome to better plan treatment for future patients. I. Creation of human tumor atlas. Catalog the evolution of genetic lesions and cellular interactions in tumor/immune/other cells in tumor microenvironment from the earliest detected lesions to metastasis and develop predictive models J. Development of new enabling technologies. Support development of technologies to accelerate testing of therapies and tumor characterization. Blue Ribbon Panel 2016
22 Process for Implementation of BRP Recommendations NCI Leadership Implementation Coordinating Committee Implementation Partnership Committee Cancer Moonshot Implementation Teams (CMIT) Aligned with BRP Recommendations
23 Cancer Moonshot Update: Status of FY17 Initiatives RFAs: Cancer Immune Monitoring and Analysis Centers Cancer Immunologic Data Commons Canine Immunotherapy Trials Coordinating Center for Canine Immunotherapy Consortium for Pancreatic Ductal Adenocarcinoma Translational Studies PDAC Resource Center Drug Resistance and Sensitivity New Enabling Technologies Administrative Supplements: Gene Fusions in Pediatric Sarcomas Smoking Cessation Program Tobacco Control in Cancer Patients Symptom Management Autoimmune Sequelae with NIAID New Technologies PDX Development and Trial Centers PDX Data Commons Center
24 Cancer Moonshot Update: Status of FY17 Initiatives FY 17 Moonshot Contracts Category Fusion Oncoproteins in Childhood Cancers Generation of Human Tumor Atlases National Cancer Data Ecosystem Network for Direct Patient Engagement New Enabling Technologies Retrospective Analysis of Biospecimens from Patients Treated with Standard of Care Therapeutic Target Identification to Overcome Drug Resistance Cancer Immunotherapy Translational Science (Pediatric and Adult) Prevention and Early Detection: Implementation Science Contract Pediatric Core BioBank Tumor Atlas Pilot Program Cancer Data Ecosystem Pilots FNLCR Contract Expand Data Commons and Data Sharing - FNLCR contract NCI Office of Data Coordination BioBank DOE-NCI Collaborations: Predictive models for preclinical screening; RAS-complex interaction modeling; Integration, analysis, and modeling of population information DOE-NCI Collaborations: Predictive models for preclinical screening; RAS-complex interaction modeling; Integration, analysis, and modeling of population information (DCCPS) Retrospective tumor characterization analysis for patients on trials Human Cancer Models Initiative (HCMI) - FLNCR Human Cancer Models Initiative (HCMI) - OA Contracts Clinical Center Lab Infrastructure for New Immunotherapy Cell-related Research (National Center for Cell-based Therapy) (Intramural) Costa Rica HPV Vaccine Trial Contract (Intramural)
25 Generation of Human Tumor Atlases Status of FY18 RFAs RFA Receipt Date Number of Apps CMIT RFA Title RFA Number Pediatric Immunotherapy Pediatric Immunotherapy Discovery and Development Network (PI-DDN)(U54) RFA-CA /19/17 3 Network Pediatric Immunotherapy Discovery and Development Network (PI-DDN)(U01) RFA-CA /19/17 25 Immuno-Oncology Translation Network (IOTN): Cancer Immunotherapy Research Projects (U01) RFA-CA /16/18 72 (56 NCI) Adult Immunotherapy Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01) RFA-CA /16/18 12 (9 NCI) Network Immuno-Oncology Translation Network (IOTN): Data Management and Resource-Sharing Center (DMRC) (U24) RFA-CA /16/18 3 Immuno-Oncology Translation Network (IOTN): Cellular Immunotherapy Data Resource (CIDR) (U24) RFA-CA /16/18 1 Target ID to Overcome Mechanisms of Cancer Drug Resistance and Sensitivity: Drug Resistance Coordinating Center (U24) RFA-CA /5/18 0 Fusion Oncoproteins Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54) RFA-CA /15/17 11 Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability (U01) RFA-CA /18/18 7 Symptom Management Research Centers for Improving Management of Symptoms During and Following Cancer Treatment (UM1) RFA-CA /17/18 10 Coordinating Center for Research Centers for Improving Management of Symptoms During and Following Cancer RFA-CA /17/18 6 Treatment (U24) High Risk Cancers Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01) RFA-CA /9/18 23 Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS)(UG3/UH3) RFA-CA /18/18 16 Prevention and Screening Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS): Coordinating RFA-CA /18/18 7 Center (U24) Human Tumor Atlas Research Centers (U2C) RFA-CA /18/18 18 Pre-Cancer Atlas (PCA) Research Centers (U2C) RFA-CA /18/18 20 Human Tumor Atlas Network: Data Coordinating Center (U24) RFA-CA /18/18 6
26 Ongoing Partnership Discussions NCI Council of Research Advocates (NCRA) Rare Tumor Patient Engagement Network VA Connected Health Direct Patient Engagement Coalition Against Childhood Cancer (CAC2) Fusion Oncoproteins St. Baldrick s Foundation Pediatric Immunotherapy AACR Immunotherapy workshops OnPar All moonshot areas Chan-Zuckerberg Initiative Human Tumor Atlas Partnerships_CancerMoonshot@nih.gov
27 Status of FY17 Initiatives (Cont.) Partnerships Partnership for Accelerating Cancer Therapies APPOLLO Intramural National Center for Cell-based Therapy (CCR) Rare Tumor Patient Engagement Network PSMA-PET Imaging of High Risk Prostate Cancer Divide and Conquer with Combinations (DiCoCo): A Master Trial in Lymphoma Understanding, Measuring and Preventing Chronic GVHD across the lifespan
NCI Cancer Moonshot. Christine Siemon National Cancer Institute, NIH. November 30, 2017
NCI Cancer Moonshot Christine Siemon National Cancer Institute, NIH November 30, 2017 Presidential Memo 2016 Overall Goals of the Cancer Moonshot Accelerate progress in cancer, including prevention & screening
More informationBRP update from the NCI Acting Director
BRP update from the NCI Acting Director Douglas R. Lowy Acting Director, National Cancer Institute National Institutes of Health BRP Virtual Meeting May 9, 2017 NCI APPROPRIATIONS 2013-2017 (in billions)
More informationImmediate Past President National Medical Association
Improved Survival but Continued Disparities in Cancer: The 1971 National Cancer Act through Moonshot 2017 Edith Peterson Mitchell, MD, FACP, FCPP Clinical Professor of Medicine and Medical Oncology Department
More informationCancer Moonshot Blue Ribbon Panel Report.
Cancer Moonshot Blue Ribbon Panel Report www.cancer.gov/brp Goals of the Cancer Moonshot Accelerate progress in cancer, including prevention & screening From cutting edge basic research to wider uptake
More informationClinical Trials in Prostate Cancer: To do or not To Do?
Clinical Trials in Prostate Cancer: To do or not To Do? Edith Peterson Mitchell, MD, FACP Clinical Professor of Medicine and Medical Oncology Associate Director for Diversity Programs Sidney Kimmel Cancer
More informationUpdate on the NCI Cancer Centers Program Henry P. Ciolino, Ph.D. Director, Office of Cancer Centers
Update on the NCI Cancer Centers Program Henry P. Ciolino, Ph.D. Director, Office of Cancer Centers April 30, 2017 History of the CCSG Funding Opportunity Announcement What hasn t changed What has changed
More informationOutcomes of the Cancer Moonshot: A Blue Print for Accelerating Progress
Outcomes of the Cancer Moonshot: A Blue Print for Accelerating Progress Elizabeth M. Jaffee Co-Chair, Cancer Moonshot Blue Ribbon Panel The Sidney Kimmel Cancer Center at Johns Hopkins December 13, 2016
More informationImpressions of a New NCI Director: Big Data
Impressions of a New NCI Director: Big Data Norman E. Sharpless, M.D. Cancer Informatics for Cancer Centers April 3, 2018 www.cancer.gov www.cancer.gov/espanol October 17, 2018 NCI: Leading the National
More informationMurtha Cancer Center The DoD Cancer Center of Excellence
Accelerating Progress against Cancer through Collaboration Center of Excellence Oversight Board September 10, 2013 Colonel Craig D. Shriver, MC, USA. FACS Director 1 Summary Murtha Cancer Center Overview
More informationAccelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS)
Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS) Wynne Norton, PhD Division of Cancer Control and Population Sciences National Cancer Institute Lightning Round:
More informationOVAC FY 2017 Appropriations Requests
OVAC FY 2017 Appropriations Requests One Voice Against Cancer (OVAC), a broad coalition of cancer-related organizations representing millions of Americans, supports the goals of the Cancer Moonshot initiative
More informationREPORT. A Model Clinical Trials System for the 21st Century
www.georgiacore.org www.georgiacancertrials.org REPORT A Model Clinical Trials System for the 21st Century A Response to the Institute of Medicine s 2010 Report A National Cancer Clinical Trials System
More informationSustain and Seize Cancer Research Opportunities
One Voice Against Cancer (OVAC) appreciates the opportunity to submit written comments for the record regarding funding for cancer programs for research, prevention, detection, and treatment as well as
More informationWashington, DC Washington, DC Washington, DC Washington, DC 20510
March 12, 2018 The Honorable Thad Cochran The Honorable Patrick Leahy Chairman Vice Chairman Committee on Appropriations Committee on Appropriations Washington, DC 20510 Washington, DC 20510 The Honorable
More informationRecommendations from Programmatic Review on Disease Pathway Management. Date: June 12, 2010
Recommendations from Programmatic Review on Disease Pathway Management Date: June 12, 2010 Cancer Quality Council of Ontario: Context CQCO founded in 2002 on the recommendations of Ministry review of cancer
More informationComprehensive Cancer Control Technical Assistance Training and Communication Plan. PI: Mandi Pratt-Chapman, MA. Cooperative Agreement #1U38DP
Comprehensive Cancer Control Technical Assistance Training and Communication Plan PI: Mandi Pratt-Chapman, MA Cooperative Agreement #1U38DP004972-01 July 2014 Acknowledgement: This work was supported by
More informationThe National Academies
The National Academies Building the 21 st Century: U.S. China Cooperation on Science Technology and Innovation Anna D. Barker, PhD Deputy Director, NCI May 18, 2010 By 2020, Cancer Could Kill 10.3 Million
More information2017 REPORT ON PROGRAM MERIT AND PROGRESS PURSUANT TO TEXAS HEALTH & SAFETY CODE (C)
MEMORANDUM To: OVERSIGHT COMMITTEE MEMBERS From: WAYNE ROBERTS, CHIEF EXECUTIVE OFFICER Subject: FY 2017 REPORT ON PROGRAM MERIT AND PROGRESS PURSUANT TO TEXAS HEALTH & SAFETY CODE 102.260(C) Date: FEBRUARY
More informationSpontaneous canine malignancies: Models for precision cancer medicine
National Cancer Institute Spontaneous canine malignancies: Models for precision cancer medicine Amy K. LeBlanc, DVM DACVIM (Oncology) Director, NCI Comparative Oncology Program NIH/NCI Center for Cancer
More informationUpdate of The National Vaccine Plan
Update of The National Vaccine Plan Raymond A. Strikas, MD National Vaccine Program Office Department of Health and Human Services Presentation Outline Statutory basis for the National Vaccine Program
More informationLondon Regional Cancer Program
London Regional Cancer Program Table of Contents Mission, Vision and Values...1 Key Areas and Directions... 2 Leading in Patient Care and Service Delivery... 2 Improving Quality and Safety... 5 Strengthening
More informationCRCHD Network Initiatives
CRCHD Network Initiatives GMaP & NON Anil Wali, PhD July 19, 2017 CRCHD Network Programs Geographic Management of Cancer Health Disparities Program (GMaP) GMaP is a seven-region network that fosters collaboration,
More informationthe Office of Research Application Portal: Materials to submit:
Title: PAR 17 237: Centers for AIDS Research (P30) Slots: 1 Internal Deadline: LOI: External Deadline: Award Information: Submission Process: May 26, 2018, 5pm PDT 30 days prior to the application due
More informationIARC A UNIQUE AGENCY. Cancer research for cancer prevention
IARC A UNIQUE AGENCY Cancer research for cancer prevention Director s message IARC is a unique organization. For the past 50 years, the Agency has been making important contributions to the global fight
More informationNational Cancer Institute
National Cancer Institute U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute Community Oncology Research Program (NCORP) Institute of Medicine Implementing
More informationThe National Cancer Institute Community Oncology Research Program (NCORP) A Local Story
The National Cancer Institute Community Oncology Research Program (NCORP) A Local Story Connie Szczepanek RN, BSN Director Cancer Research Consortium of West Michigan (CRCWM NCORP) Page 1 of 37 1 Cancer
More informationSpontaneous canine malignancies: Models for precision cancer medicine
National Cancer Institute Spontaneous canine malignancies: Models for precision cancer medicine Amy K. LeBlanc, DVM DACVIM (Oncology) Director, NCI Comparative Oncology Program NIH/NCI Center for Cancer
More informationSD Cancer Coalition 2016: Year in Review
SD Cancer Coalition 2016: Year in Review The South Dakota Comprehensive Cancer Control Program (SD CCCP) began in 2005 with the goal of reducing the burden of cancer and promoting access to cancer prevention
More informationCommunity Benefit Strategic Implementation Plan. Better together.
Community Benefit Strategic Implementation Plan 2016 2019 Better together. Table of Contents Introduction... 4 Priority 1: Community Health Infrastructure... 5 Objective 1.1: Focus resources strategically
More informationNational Survivorship and QoL Research:
National Survivorship and QoL Research: Impact on Interventions, Guidelines, and Resources Kevin D. Stein, PhD, Vice President, Behavioral Research, Director, Behavioral Research Center, American Cancer
More information2016 NYC Hep B Coalition Work Plan
The NYC Hepatitis B Coalition mission is to coordinate efforts to prevent, manage and reduce hepatitis B among all residents of New York City. The coalition seeks to foster an inclusive collaboration among
More informationNational Comprehensive Cancer Control Program Reviewer Training March 16, 2017
FOA DP17-1701 Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations National Comprehensive Cancer Control Program Reviewer Training March 16, 2017 Angela Moore, MPH, Team
More informationPhoto courtesy Conrad N. Hilton Foundation. EVALUATION OF THE Conrad N. Hilton Foundation Chronic Homelessness Initiative 2015 REPORT
Photo courtesy Conrad N. Hilton Foundation. EVALUATION OF THE Conrad N. Hilton Foundation Chronic Homelessness Initiative 2015 REPORT December 2015 Executive Summary Under a September 2011 contract with
More informationWhere Are We Going? Lisa C. Richardson, MD, MPH Division Director
Where Are We Going? Lisa C. Richardson, MD, MPH Division Director Oncology Nursing Society Hill Day September 6, 2017 Good afternoon. RELIABLE TRUSTED SCIENTIFIC DCPC DCPC RELIABLE TRUSTED SCIENTIFIC
More informationProgress Update June 2017 Lay Summary Funding: $6,000,000 Grant Funded: July 2015 Dream Team Members Dream Team Leader:
SU2C -Ovarian Cancer Research Fund Alliance-National Ovarian Cancer Coalition Dream Team Translational Research Grant: DNA Repair Therapies for Ovarian Cancer AND SU2C Catalyst Merck-Supported Supplemental
More informationVISION» FOCUS DISCOVERY» CREATION
The Women s Health Research Institute at Northwestern University is turning possibility into reality. The possibility that we can improve women s health by requiring that all research studies put greater
More informationThe Academy Capitol Forum: Meet the Experts. Diagnosing Which Health Treatments Improve Outcomes: A PCORI Overview and How to Get Involved
The Academy Capitol Forum: Meet the Experts Diagnosing Which Health Treatments Improve Outcomes: A PCORI Overview and How to Get Involved Presenter: Gregory Martin, Deputy Directory of Stakeholder Engagement
More informationCancer Action Coalition of Virginia Report to the Governor, General Assembly, and the Joint Commission on Health Care.
Cancer Action Coalition of Virginia Report to the Governor, General Assembly, and the Joint Commission on Health Care January 23, 2019 Contents CACV Mission and Members... 2 Prevention Accomplishments...
More informationCONGENITAL HEART PUBLIC HEALTH CONSORTIUM
CONGENITAL HEART PUBLIC HEALTH CONSORTIUM Impact and opportunity of a public health approach to congenital heart defects WHO WE ARE In 2009, various organizations across federal, state and local communities
More informationPRELIMINARY PROGRAM MAY 31 - JUNE 4, 2019
MONDAY, JUNE 3, 2019 7:30 AM - 9:15 AM HIGHLIGHTS OF THE DAY 8:00 AM - 9:00 AM S 8:00 AM - 9:15 AM S S 8:00 AM - 11:00 AM S Highlights of the Day Session II Bringing New and Innovative Glioblastoma Treatments
More informationHealth Education. Health Education. Regional Oncology Communications and Health Promotions
Regional Oncology Communications and Health Promotions International Cancer Conference The International Cancer Conference was established in 2003 and has existed for 9 years. It was the first conference
More informationMODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit
MODULE SIX Global TB Institutions and Policy Framework Treatment Action Group TB/HIV Advocacy Toolkit 1 Topics to be Covered Global TB policy and coordinating structures The Stop TB Strategy TB/HIV collaborative
More informationASBMR. Institute of Musculoskeletal Health and Arthritis (IMHA) Dr. Hani El-Gabalawy Scientific Director Canadian Institutes of Health Research
Institute of Musculoskeletal Health and Arthritis (IMHA) ASBMR October 6, 2013 Dr. Hani El-Gabalawy Scientific Director Canadian Institutes of Health Research Welcome Our goals: Introduce our team Provide
More informationFighting Cancer with Data: Perspectives on MD Anderson Moon Shot Program
Fighting Cancer with Data: Perspectives on MD Anderson Moon Shot Program Joxel Garcia, MD, MBA Executive Director, Cancer Prevention and Control Platform Member, Moon Shots Program Leadership Team The
More informationMinistry of Health and Long-Term Care. Palliative Care. Follow-Up on VFM Section 3.08, 2014 Annual Report RECOMMENDATION STATUS OVERVIEW
Chapter 1 Section 1.08 Ministry of Health and Long-Term Care Palliative Care Follow-Up on VFM Section 3.08, 2014 Annual Report RECOMMENDATION STATUS OVERVIEW # of Status of Actions Recommended Actions
More informationNCI s Office of of Centers, Training & Resources: Fostering Progress in in Cancer Health Disparities Research
NCI s Office of of Centers, Training & Resources: Fostering Progress in in Cancer Health Disparities Research July July 17-19, 17-19, 2006 2006 Cancer Cancer Health Health Disparities Disparities Summit
More informationImpact of the Cancer Prevention and Control Research Network April 2018
Impact of the Cancer Prevention and Control Research Network April 2018 A report on the activities, productivity, and impact of CPCRN over the past year, across the current funding cycle, and across all
More informationTRANS-NIH PLAN FOR HIV RELATED RESEARCH
National Institutes of Health FY 2018 TRANS-NIH PLAN FOR HIV RELATED RESEARCH Prepared by the Office of AIDS Research Maureen M. Goodenow, Ph.D. NIH Associate Director for AIDS Research and Director, Office
More informationTranslating Duke Health. Accelerating discovery and its translation
Translating Duke Health Accelerating discovery and its translation Translating Duke Health Biomedical discovery is accelerating innovative and revolutionary advancements in our understanding of human biology,
More informationProgram Priorities 2018
Program Priorities 2018 Blank Page 2 CONTENTS: About CPRIT Program Priorities Project...Page 5 Process to Develop Program Priorities...Page 6 Scope of Program Priorities Project...Page 6 CPRIT s Long-Term
More informationSWOG Plenary I Translational Medicine Science as the Foundation for Rapid and Meaningful Advances in Oncology
SWOG Plenary I Translational Medicine Science as the Foundation for Rapid and Meaningful Advances in Oncology Lee M. Ellis, MD SWOG Vice Chair, Translational Medicine Departments of Surgical Oncology and
More informationStrategic Plan for Science
Strategic Plan for Science 2018 2020 OVERVIEW Autism Speaks Mission Autism Speaks is dedicated to promoting solutions, across the spectrum and throughout the lifespan, to meet the needs of individuals
More informationQOPI and the Rapid Learning Oncology Care System. Copyright 2011 American Society of Clinical Oncology. All rights reserved 1
QOPI and the Rapid Learning Oncology Care System Copyright 2011 American Society of Clinical Oncology. All rights reserved 1 Program Description Quality improvement program for outpatient hematologyoncology
More informationIntroduction. Legislation & Policy Context
Consumer Participation Plan 2017-2018 1 Introduction Barwon South Western Regional Integrated Cancer Service (BSWRICS) is committed to improving the experiences and outcomes of those affected by cancer
More informationDP Program 2 National Comprehensive Cancer Control Program. Objective Reviewer s Tool March 2017
DP17-1701 Program 2 National Comprehensive Cancer Control Program Objective Reviewer s Tool March 2017 Approach (0-40 total points) Describes the cancer burden in the applicant s jurisdiction? (5) Clearly
More informationGeorgia Cancer Quality Information Exchange
Georgia Cancer Quality Information Exchange Measuring Progress, Motivating Change William J. Todd President & Chief Executive Officer October 5, 2009 Hamilton Jordan 1944 2008 Georgia Cancer Coalition
More informationNational Alzheimer s project U.S.
National Alzheimer s project U.S. Requires the Secretary of the U.S. Department of Health and Human Services (HHS) to establish the National Alzheimer s Project to: Create and maintain an integrated national
More informationParent Partnerships: Family-to-Family Health Information Centers: We Are All Part of the Process
AMCHP Conference -Leadership Education in Neurodevelopmental & Related Disabilities Parent Partnerships: Family-to-Family Health Information Centers: We Are All Part of the Process March 3, 2007 Diana
More informationDelphi Survey Results. MPIs: Drs. William Dale, Arti Hurria, Supriya Mohile
Delphi Survey Results MPIs: Drs. William Dale, Arti Hurria, Supriya Mohile Cancer and Aging Research Group (CARG) A Delphi Investigation Of Geriatric Oncology Experts Sustainable Infrastructure That Supports
More informationCancer Health Disparities Research Leading to Elimination
COMPREHENSIVE CANCER CENTER Cancer Health Disparities Research Leading to Elimination Edward E. Partridge, MD, Director Comprehensive Cancer Center Professor of Gynecologic Oncology Evalina B. Spencer
More informationIncreasing Adult Immunization Rates in the US Through Data and Quality: A Roadmap
Increasing Adult Immunization Rates in the US Through Data and Quality: A Roadmap Avalere Health An Inovalon Company November 16, 2017 In Partnership with GSK Agenda 1 2 3 4 5 Welcome & Introductions Overview:
More informationOpportunities in Pain Research with the NIH HEAL Initiative
Opportunities in Pain Research with the NIH HEAL Initiative Clinton Wright, M.D. Director, Division of Clinical Research National Institute of Neurological Disorders and Stroke, NIH September 20, 2018
More informationInnovator Case Studies: Oncology Networks
Innovator Case Studies: Oncology Networks J. Ike Nicoll Chief Executive Officer Cancer Clinics of Excellence Alan Armer, Ph.D. Vice President, Research & Development Catholic Health Initiatives Cancer
More informationThe summit and its purpose
Sponsors: 1 The summit and its purpose The Translational Hearing Research Summit: Biological and Pharmacological Approaches was an international summit that gathered 159 delegates, from 14 countries to
More informationNIH HEAL Initiative: Program Update and Funding Opportunities for Pain Research Available through NIH
NIH HEAL Initiative: Program Update and Funding Opportunities for Pain Research Available through NIH AAMC Webinar November 8, 2018 Walter J. Koroshetz, MD Director, National Institute of Neurological
More informationAdvancing Therapeutic Development for Pain and Opioid Use Disorder through Public-Private Partnerships
The National Academies of SCIENCES ENGINEERING MEDICINE Advancing Therapeutic Development for Pain and Opioid Use Disorder through Public-Private Partnerships Leadership The NIH Pain Consortium Mission
More informationHealth for Humanity 2020 Goals 2
2017 for Humanity Report Better for Humanity 2020 s 2 At Johnson & Johnson, we aspire to profoundly change the trajectory of health for humanity. Our for Humanity 2020 s, underpinned by 16 targets, focus
More informationNew Opportunities in Cancer Research National Academy of Sciences Advancing Health Research in Poland and the United States December 3, 2009
New Opportunities in Cancer Research National Academy of Sciences Advancing Health Research in Poland and the United States December 3, 2009 Anna D. Barker, Ph.D. Deputy Director, NCI Cancer is a Current
More informationNational Cancer Programme. Work Plan 2014/15
National Cancer Programme Work Plan 2014/15 Citation: Ministry of Health. 2014. National Cancer Programme: Work Plan 2014/15. Wellington: Ministry of Health. Published in December 2014 by the Ministry
More informationNational Cancer Programme. Work Plan 2015/16
National Cancer Programme Work Plan 2015/16 Citation: Ministry of Health. 2015. National Cancer Programme: Work plan 2015/16. Wellington: Ministry of Health. Published in October 2015 by the Ministry of
More informationREPORT TO CONGRESS Multi-Disciplinary Brain Research and Data Sharing Efforts September 2013 The estimated cost of report or study for the Department of Defense is approximately $2,540 for the 2013 Fiscal
More informationNCI, Prevention, and Screening
NCI, Prevention, and Screening Doug Lowy, M.D. Acting Director, National Cancer Institute, NIH AACR Cancer Prevention Summit February 3, 2016 Outline of Presentation Cancer mortality trends NCI budget
More informationThe future of cancer care... now 1. Strategic Plan
2017 2021 The future of cancer care... now 1 Strategic Plan 2 Duke Cancer Institute 2017 2021 Strategic Plan Mission: We discover, develop and deliver the future of cancer care... now. Vision: At Duke
More informationWHERE NEXT FOR CANCER SERVICES IN NORTHERN IRELAND? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE
WHERE NEXT FOR CANCER SERVICES IN NORTHERN IRELAND? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE EXECUTIVE SUMMARY Incidence of cancer is rising, with one in two people born after 1960 expected
More informationFY12 FY14 Strategic Plan
FY12 FY14 Strategic Plan Overview: Currently there are more than 5 million people with Alzheimer s disease in the United States and 35 million worldwide. These numbers are expected to skyrocket to as many
More informationBD-STEP: Tackling Key Issues Across Cancer Research and Care
BD-STEP: Tackling Key Issues Across Cancer Research and Care Michelle Berny-Lang, Ph.D. Program Director Center for Strategic Scientific Initiatives Office of the Director, National Cancer Institute BD-STEP
More informationC-Change Making the Business Case Questions & Answers
C-Change Making the Business Case Questions & Answers How To Use This Document Following are a set of questions and answers about C-Change s multi-year Making the Business Case for cancer prevention and
More informationTHE UC SANTA CRUZ GENOMICS INSTITUTE. David Haussler Distinguished Professor, Biomolecular Engineering Scientific Director
THE UC SANTA CRUZ GENOMICS INSTITUTE David Haussler Distinguished Professor, Biomolecular Engineering Scientific Director April 8, 2015 OUR MISSION Unlocking the world s genomic data to accelerate medical
More information6 Opportunities for Improving Pathways to Market: A Global Perspective on Dementia
6 Opportunities for Improving Pathways to Market: A Global Perspective on Dementia Raj Long Senior Regulatory Officer Bill & Melinda Gates Foundation Director Dementia Integrated Development UK HMG World
More informationImproving Women s Health Through the Prevention and Control of Chronic Disease
Improving Women s Health Through the Prevention and Control of Chronic Disease Pamela Protzel Berman, MPH, Doctoral Candidate Deputy Director Division of Cancer Prevention and Control, CDC December 10,
More informationPotential Opportunities for Collaboration with Pancreatic U01s
Potential Opportunities for Collaboration with Pancreatic U01s Sudhir Srivastava, PhD, MPH Chief, Cancer Biomarkers Research Group Division of Cancer Prevention Background Recalcitrant Cancer Research
More informationPursuing Quality Lives
Pursuing Quality Lives Supporting Ohioans with Autism Across Agencies, Across the State, Across the Lifespan May 2018 Interagency Work Pursuing Quality Group Lives on Autism1 Ohio has a rich and long-standing
More informationGavi s private sector engagement approach
Gavi s 2016-2020 private sector engagement approach SCALING INNOVATION FOR IMPACT Gavi Board technical briefing session 21 June 2016 Geneva, Switzerland Reaching further, together www.gavi.org A HISTORY
More informationThe American College of Obstetricians and Gynecologists Office of Global Women s Health Strategic Plan
The American College of Obstetricians and Gynecologists Office of Global Women s Health Strategic Plan 2019 2021 PROVIDING EVERY WOMAN, EVERYWHERE HIGH-QUALITY HEALTH CARE The American College of Obstetricians
More informationPatient-Centered Cancer Treatment Planning: Improving the Quality of Oncology Care
Patient-Centered Cancer Treatment Planning: Improving the Quality of Oncology Care Carolyn M. Clancy, MD Director Agency for Healthcare Research and Quality IOM National Cancer Policy Forum and the National
More informationNIH Alzheimer s Disease Centers Panel Recommendations
NIH Alzheimer s Disease Centers Panel Recommendations In June, 2017 NIA engaged leading experts from academia, industry and non-profit foundations, working in Alzheimer s and other complex diseases, in
More informationUnderstanding the AAP
Understanding the AAP A Guide for Families and Youth October 2015 AAP FamilY Partnerships Network Executive Committee The mission of the AAP is to attain optimal physical, mental and social health and
More informationThe Current Landscape of Nurse Navigators: Oncology and the Impact on Outcomes
The Current Landscape of Nurse Navigators: Oncology and the Impact on Outcomes SHERYL RILEY RN, OCN, CMCN DIRECTOR OF CLINICAL SERVICES SAI SYSTEMS SRILEY@SAISYSTEMS.COM 2015 SAI SYSTEMS INTERNATIONAL
More informationResearch Announcements for the Week Ending March 21, 2014
Research Announcements for the Week Ending March 21, 2014 Compiled by Julie C. Kong, MEd, RD, LN,CRA Director of Research Services, UIC School of Public Health 1. Aging 2. Cancer 3. Hepatitis C 4. International
More informationBATTELLE CANCER RESEARCH INITIATIVE. Bridging the Gap between Discovery and Application
BATTELLE CANCER RESEARCH INITIATIVE Bridging the Gap between Discovery and Application ANSWERING THE CALL TO END CANCER Defeating cancer is among the most complex and ambitious goals mankind has ever attempted.
More informationGlobal Strategies to Improve Cancer Care and Control
Women s Empowerment Cancer Advocacy Network (WE CAN) Conference Global Strategies to Improve Cancer Care and Control Tbilisi, Georgia October 15-16, 2013 Julie R. Gralow, M.D. Jill Bennett Endowed Professor
More informationNORDIC CONFERENCE ON RARE DISEASES
www.eurordis.org NORDIC CONFERENCE ON RARE DISEASES 31 May 2012, Reykjavik, Iceland www.eurordis.org RARE DISEASES IN EUROPE Terkel ANDERSEN President of EURORDIS European Organisation for Rare Diseases
More informationOncology Drug Development
Oncology Drug Development Advantages and challenges of using stratified clinical studies Simon J Hollingsworth The 18th Anti-Tumour Drug Development Forum 21 February Japan Stratified Medicine In The Clinic
More informationCPRIT Overview. Cancer Centers Administrators Forum April 4, 2016
CPRIT Overview Cancer Centers Administrators Forum April 4, 2016 CPRIT s Unique Role in the Fight Against Cancer Overview: Created by the Texas Legislature and citizens in 2007 $3 billion over 10 years
More informationFacts and Resources: Pediatric Cancer Survivorship
Facts and Resources: Pediatric Cancer Survivorship Overview The term "cancer survivors" refers to those people who have been diagnosed with cancer and the people in their lives who are affected by the
More informationPCORI s Role in Supporting CER
PCORI s Role in Supporting CER Ayodola Anise, MHS Program Officer, Addressing Disparities Program December 8, 2014 1 Objectives Background on PCORI Our national priorities and research PCORI supports Focus
More informationNeurofibromatosis (NF) Center
Washington University Neurofibromatosis (NF) Center THE NF CENTER: EXCEPTIONAL CARE THROUGH GROUNDBREAKING RESEARCH An international leader in research and treatment of neurofibromatosis (NF), the Washington
More informationNCI-designated Cancer Centers & Colorectal Cancer Screening
NCI-designated Cancer Centers & Colorectal Cancer Screening MD Anderson s Cancer Prevention & Control Platform Transforming Science into Actions to Realize the Promise of Prevention & Control The function
More informationWREN Forum September 12, Rosa Hand, MS, RDN, LD Senior Manager, Dietetics Practice Based Research Network (DPBRN)
Engaging Registered Dietitian Nutritionists in a Research Network: Building on the first ten years WREN Forum September 12, 2013 Rosa Hand, MS, RDN, LD Senior Manager, Dietetics Practice Based Research
More informationPresident's Cancer Panel 2014 Report HPV Vaccination: Progress and Activities
Lisa Paradis, MPH Research Analyst, President s Cancer Panel President's Cancer Panel 2014 Report HPV Vaccination: Progress and Activities Increasing HPV Vaccination in the United States: A Collaboration
More information